Singapore markets close in 6 hours 17 minutes

Akari Therapeutics, Plc (CLA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4500+0.1800 (+14.17%)
At close: 09:24AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
7,825
9,561
9,133
8,820
Selling general and administrative
13,412
13,527
8,081
9,161
Total operating expenses
21,238
23,088
17,214
17,981
Operating income or loss
-21,238
-23,088
-17,214
-17,981
Total other income/expenses net
11,251
5,294
-220.701
885.742
Income before tax
-9,890
-17,748
-17,424
-17,082
Income from continuing operations
-9,890
-17,748
-17,424
-17,082
Net income
-9,890
-17,748
-17,424
-17,082
Net income available to common shareholders
-9,890
-17,748
-17,424
-17,082
Basic EPS
-2.52
-5.69
-8.12
-20.00
Diluted EPS
-2.52
-5.69
-8.12
-20.00
Basic average shares
3,907
3,122
2,146
1,580
Diluted average shares
3,907
3,122
2,146
1,580